1. Eaton W, Armenian H, Gallo J, Pratt L, Ford E. Depression and risk for onset of type II diabetes: A prospective population-based study. Diabetes Care. 1996. 22:1097–1102.
2. Fisher L, Skaff MM, Chesla CA, Kanter RA, Mullan JT. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care. 2001. 24:1751–1757.
3. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997. 20:585–590.
4. Rush WA, Whitebird RR, Rush MR, Solberg LI, O'Connor PJ. Depression in Patients with Diabetes: Does It impact clinical goals? J Am Board Fam Med. 2008. 21:392–397.
5. Katon W, von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care. 2004. 27:914–920.
6. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med. 2003. 65:376–383.
7. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med. 2002. 23:51–61.
8. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001. 63:619–630.
9. Kessler RC, Berglund P, Demler O. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003. 289:3095–3105.
10. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001. 24:1069–1078.
11. Noh JH, Park JK, Lee HJ, Kwon SK, Lee SH, Park JH, Ko KS, Rhee BD, Lim KH, Kim DJ. Depressive symptoms of type 2 diabetics treated with insulin compared to diabetics taking oral anti-diabetic drugs: a Korean study. Diabetes Res Clin Pract. 2005. 69:243–282.
12. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005. 28:2668–2672.
13. Egede LG, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002. 25:464–470.
14. Baer L, Jacobs DG, Meszler-Reizes J, Blais M. Development of a brief screening instrument: the HANDS. Psychother Psychosom. 2000. 69:35–41.
15. Toobert DJ, Glasgow RE. Assessing diabetes self-management: the summary of diabetes self-care activities questionnaire. Handbook of Psychology and Diabetes. 1994. Harwood Academic;351–375.
16. Toobert DJ, Hampson SE, Glasgow RE. The Summary of Diabetes Self-Care Activities Measure Results from 7 studies and a revised scale Diabete. Care. 2000. 23:943–950.
17. Eigenmann CA, Colagiuri R, Skinner TC, Trevena L. Are current psychometric tools suitable for measuring outcomes of diabetes education? Diabet Med. 2009. 26:425–436.
18. Musselman DL, Betan E, Larsen H, Phillips LS. The relationship of depression to diabetes-Type 1 and Type 2: Epidemiology, biology, and treatment. Biol Psychiatry. 2003. 54:317–329.
19. Yoo HJ. Pharmachotherapy for depressive disorder in patients with diabetes mellitus. Korean Diabetes J. 2008. 301–308.
20. Milano AF, Singer RB. Mortality in co-morbidity (II)-excess death rates derived from a follow-up study on 10025 subjects divided into groups with or without depression and diabetes mellitus. J Insur Med. 2007. 39:160–166.
21. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005. 161:652–660.
22. Jeffrey S, Steven A, Enrico C. Depression, Self-Care, and Medication Adherence in Type 2 Diabetes: Relationships across the full range of symptom Severity. Diabetes Care. 2007. 30:2222–2227.
23. Ciechanowski PS, Katon WJ, Russo JE. Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000. 160:3278–3285.
24. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, selfcare and glucose control in diabetes. Gen Hosp Psychiatry. 2003. 25:246–252.
25. Lin EH, Katon W, Von Korff M, Rutter C. Relationship of depression and diabetes self-care, medication adherence, and preventative care. Diabetes Care. 2004. 27:2154–2160.
26. Park HS, Hong YS, Lee HJ, Ha EH, Sung YA. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol. 2004. 57:978–984.
27. Kalsekar ID, Madhaven SS, Amonkar MM, Makela EH, Elswick BL. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother. 2006. 40:605–611.
28. Kilbourne AM, Reynolds CF, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005. 13:202–210.
29. Lustman P, Anderson R, Freedland K. Depression and Poor Glycemic Control A meta-analytic review of the literature. Diabetes Care. 2000. 23:934–942.
30. Winkley K, Ismail K, Landau S, Eisler I. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2006. 333:65.
31. Halford K, Goodall TA, Nicholson JM. Diet and diabetes (II): A controlled trial of problem solving to improve dietary selfmanagement in patients with insulin-depenedent diabetes. Psychology and Health. 1997. 12:231–238.
32. Stenström U, Göth A, Carlsson C, Andersson PO. Stress management training as related to glycemic control and mood in adults with Type 1 diabetes mellitus. Diabetes Res Clin Pract. 2003. 60:147–152.
33. van der Ven NC, Hogenelst MH, Tromp-Wever AM. Short-term effects of cognitive behavioural group training (CBGT) in adult type 1 diabetes patients in prolonged poor glycaemic control. Diabet Med. 2005. 22:1619–1623.
34. Okamura F, Tashiro A, Utumi A. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metab Clin Exp. 2000. 49:1255–1260.